Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2012 1
2013 4
2014 5
2015 6
2016 4
2017 3
2018 7
2019 4
2020 6
2021 3
2022 5
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.
Gréa T, Jacquot G, Durand A, Mathieu C, Gasser A, Zhu C, Banerjee M, Hucteau E, Mallard J, Lopez Navarro P, Popescu BV, Thomas E, Kryza D, Sidi-Boumedine J, Ferrauto G, Gianolio E, Fleith G, Combet J, Brun S, Erb S, Cianferani S, Charbonnière LJ, Fellmann L, Mirjolet C, David L, Tillement O, Lux F, Harlepp S, Pivot X, Detappe A. Gréa T, et al. Among authors: ferrauto g. Adv Mater. 2024 Mar;36(13):e2308738. doi: 10.1002/adma.202308738. Epub 2023 Dec 17. Adv Mater. 2024. PMID: 38105299
LipoCEST and cellCEST imaging agents: opportunities and challenges.
Ferrauto G, Delli Castelli D, Di Gregorio E, Terreno E, Aime S. Ferrauto G, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jul;8(4):602-18. doi: 10.1002/wnan.1385. Epub 2016 Jan 26. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016. PMID: 26810631 Review.
Hybrid PNA-peptide hydrogels as injectable CEST-MRI agents.
Rosa E, Di Gregorio E, Ferrauto G, Diaferia C, Gallo E, Terreno E, Accardo A. Rosa E, et al. Among authors: ferrauto g. J Mater Chem B. 2024 Jul 3;12(26):6371-6383. doi: 10.1039/d4tb00358f. J Mater Chem B. 2024. PMID: 38864345
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
Di Lorenzo A, Bolli E, Ruiu R, Ferrauto G, Di Gregorio E, Avalle L, Savino A, Poggio P, Merighi IF, Riccardo F, Brancaccio M, Quaglino E, Cavallo F, Conti L. Di Lorenzo A, et al. Among authors: ferrauto g. Oncoimmunology. 2022 Jun 15;11(1):2086752. doi: 10.1080/2162402X.2022.2086752. eCollection 2022. Oncoimmunology. 2022. PMID: 35756841 Free PMC article.
50 results